/

DiscGenics

Develops regenerative cell-based therapies for degenerative spine diseases.

BiotechnologyPharmaceuticals discgenics.com ↗

Company facts

Founded: 2008
Employees: 63
Headquarters: United States
Type: Private
Funding: Series C · $50M · 2020